Daily Surveillance Blood Cultures in Children Supported With Extracorporeal Membrane Oxygenation: Single-Center,

Nicholas Schmoke1, Eunice Clark2, Christopher Nemeh1

  • 1Division of Pediatric Surgery, Department of Surgery, Columbia University Vagelos College of Physicians and Surgeons/NewYork-Presbyterian Morgan Stanley Children's Hospital, New York, NY.

Insights

Daily blood cultures for bloodstream infections (BSIs) in pediatric and neonatal extracorporeal membrane oxygenation (ECMO) patients are low-yield. Clinical signs and symptoms, not routine cultures, effectively diagnose BSIs in these critical patients.

Area of Science:

  • Pediatric critical care medicine
  • Infectious disease diagnostics
  • Extracorporeal membrane oxygenation (ECMO) support

Background:

  • Diagnosing bloodstream infections (BSIs) in patients on extracorporeal membrane oxygenation (ECMO) is challenging due to altered physiology and unreliable inflammatory markers.
  • Practice variability exists regarding routine blood cultures for BSI surveillance in ECMO centers.

Purpose of the Study:

  • To evaluate the utility of daily surveillance blood cultures for diagnosing BSIs in pediatric and neonatal ECMO patients.
  • To determine if clinical signs and laboratory findings can effectively guide BSI diagnosis in this population.

Main Methods:

  • Retrospective review of daily surveillance blood cultures from January 2021 to July 2023.
  • Analysis of clinical signs, symptoms, and laboratory results in patients with positive blood cultures.
  • Inclusion of all pediatric and neonatal patients supported on ECMO.

Main Results:

  • A cohort of 111 patients (39 neonates, 72 children) on ECMO was analyzed.
  • 3% of daily blood cultures were positive, affecting 6% of patients.
  • All positive cultures correlated with new clinical signs of infection or elevated inflammatory markers on the day of collection.

Conclusions:

  • Daily surveillance blood cultures demonstrate low yield in pediatric and neonatal ECMO patients.
  • Changes in clinical status (e.g., hypotension, hypothermia, respiratory decline) and laboratory findings are key indicators for BSI.
  • As-needed blood cultures prompted by clinical criteria are recommended to reduce unnecessary draws and costs.
Abstract

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Sputum Studies II: Culture and Sensitivity01:20

Sputum Studies II: Culture and Sensitivity

Description
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...